Karyopharm Therapeutics: 2Q Earnings Snapshot
NEWTON, Mass. (AP) _ Karyopharm Therapeutics Inc. (KPTI) on Tuesday reported a loss of $33.7 million in its second quarter.
The Newton, Massachusetts-based company said it had a loss of 60 cents per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The pharmaceutical company posted revenue of $19.9 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $6 million.
Karyopharm Therapeutics shares have increased 84 percent since the beginning of the year. The stock has more than doubled in the last 12 months.